Stay updated on Safety of PBCAR20A in NHL/CLL Clinical Trial
Sign up to get notified when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.

Latest updates to the Safety of PBCAR20A in NHL/CLL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s software/build version indicator was updated from **Revision: v3.5.0** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision indicator updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.4.3 has been applied, replacing the previous v3.4.2.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page shows a revision update from v3.4.1 to v3.4.2, replacing the previous revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check95 days agoChange DetectedThe page now displays Revision: v3.4.1 in the footer, replacing the previous v3.4.0, with no changes to the study details, eligibility criteria, or other user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check117 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Safety of PBCAR20A in NHL/CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.